The daily pill, called YCT-529, blocks a vitamin A metabolite from binding to its receptor in the testes; this action prevents the chain of gene-expression changes that are required to start the sperm-making process.

It’s not supposed to effect the rest of the body, but I assume that’s one the side effects they’d be on the lookout for in this trial